Experts: Journavx Offers Prescription to Combat Long Island’s Addiction Crisis
For decades, Americans grappling with pain have faced a stark choice: over-the-counter medications like ibuprofen, which often offer limited relief, or prescription opioids, which carry the risk of addiction adn overdose. Now, a groundbreaking third option has emerged.The U.S. Food and Drug Governance (FDA) recently approved Vertex Pharmaceuticals’ Suzetrigine, marketed as Journavx, a non-addictive, twice-daily … Read more